Inhibitex

4 Reasons Inhibitex Is No Longer A Good Buy

4 Reasons Inhibitex Is No Longer A Good Buy

Seeking Alpha

Inhibitex Shares Popped: What You Need to Know

Inhibitex Shares Popped: What You Need to Know

Motley Fool

New Drug Approvals Make Or Break Biotechnology Stocks

New Drug Approvals Make Or Break Biotechnology Stocks

Seeking Alpha

Every Biotech Is for Sale

Every Biotech Is for Sale

Motley Fool

Inhibitex rallies after reporting data from Hepatitis C Phase 1b trial

Inhibitex rallies after reporting data from Hepatitis C Phase 1b trial

Yahoo/Fly on the Wall

Inhibitex: The Negatives Of An Acquisition And The Odds Of It Occurring

Inhibitex: The Negatives Of An Acquisition And The Odds Of It Occurring

Seeking Alpha

Inhibitex

Pharmasset Shows Inhibitex-to-Achillion Drugmakers Up for Grabs: Real M&A

Pharmasset Shows Inhibitex-to-Achillion Drugmakers Up for Grabs: Real M&A

Bloomberg

Healthcare Sector: Noteworthy Insider Buys And Sells

Healthcare Sector: Noteworthy Insider Buys And Sells

Seeking Alpha

Inhibitex's Future Looks Promising

Inhibitex's Future Looks Promising

Seeking Alpha

Inhibitex Investors: Why Shares Popped 115%

Inhibitex Investors: Why Shares Popped 115%

Motley Fool